• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Chronic treatment with chlorpromazine, thioridazine or haloperidol increases striatal enkephalins and their release from rat brain.

作者信息

Herman Z S, Huzarska M, Kmieciak-Kolada K, Kowalski J

机构信息

Department of Clinical Pharmacology, Silesian School of Medicine, Katowice, Poland.

出版信息

Psychopharmacology (Berl). 1991;104(1):106-12. doi: 10.1007/BF02244563.

DOI:10.1007/BF02244563
PMID:1881995
Abstract

The aim of this paper is to study the effect of 1, 2 or 3 months' administration of chlorpromazine (CPZ), thioridazine (TDZ) (2 or 6 mg/kg) or haloperidol (HAL) (0.25 or 1 mg/kg) IP on the level of leu- and met-enkephalin (ENK) in striatum. A dose- and time-dependent increase of striatal ENK level was observed after chronic administration of the neuroleptics (NL), but 8 days after withdrawal of chronically administered NL striatal ENK was decreased. Apomorphine pretreatment significantly attenuated the elevation in ENK produced by chronic injections of NL. In perfusion fluid obtained from the lateral ventricle of animals treated 1 month with HAL a dose-dependent increase of ENK levels was observed, which was augmented by potassium ions. It is concluded that: 1) Chronic administration of neuroleptic drugs that block dopamine receptors increases the level and the release of striatal enkephalins; 2) The results support the hypothesis that activation of dopaminergic neurons tonically inhibits the synthesis of enkephalins in the striatum.

摘要

相似文献

1
Chronic treatment with chlorpromazine, thioridazine or haloperidol increases striatal enkephalins and their release from rat brain.
Psychopharmacology (Berl). 1991;104(1):106-12. doi: 10.1007/BF02244563.
2
The effect of chronic administration of dopaminergic blocking drugs on the level of enkephalins in the striatum and behavior of rats.长期给予多巴胺能阻断药物对大鼠纹状体脑啡肽水平及行为的影响。
Pol J Pharmacol Pharm. 1991 Sep-Oct;43(5):421-32.
3
Chronic treatment with atypical neuroleptics sulpiride and metoclopramide increases striatal enkephalins in rat brain.使用非典型抗精神病药物舒必利和胃复安进行长期治疗可增加大鼠脑纹状体中的脑啡肽。
Pol J Pharmacol. 1993 Sep-Dec;45(5-6):493-502.
4
Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat.
Psychopharmacology (Berl). 1981;75(4):388-90. doi: 10.1007/BF00435859.
5
Differential effects of acute and chronic administration of haloperidol on substance P and enkephalins in diverse rat brain areas.氟哌啶醇急性和慢性给药对大鼠不同脑区P物质和脑啡肽的不同影响。
Neuropsychobiology. 1986;16(4):169-74. doi: 10.1159/000118321.
6
The effect of a single temazepam administration on enkephalin content in the striatum and hypothalamus of the rat.
Pol J Pharmacol Pharm. 1983;35(4):265-9.
7
Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.氟哌啶醇和硫利达嗪诱发阿扑吗啡超敏反应的差异易感性。
Biol Psychiatry. 1982 Nov;17(11):1289-301.
8
Dopaminergic regulation of enkephalin release.脑啡肽释放的多巴胺能调节
J Neurochem. 1991 Apr;56(4):1368-75. doi: 10.1111/j.1471-4159.1991.tb11434.x.
9
Modulation of striatal enkephalinergic neurons by antipsychotic drugs.
Fed Proc. 1985 Jun;44(9):2535-9.
10
Regulation of pituitary and brain enkephalin systems by estrogen.雌激素对垂体和脑内脑啡肽系统的调节
Life Sci. 1982;31(20-21):2181-4. doi: 10.1016/0024-3205(82)90113-8.

引用本文的文献

1
The differential contribution of dopamine D(1) and D (2) receptors to mu-opioidergic immunomodulation.多巴胺D(1)和D(2)受体对μ-阿片样物质免疫调节的不同作用
Neurosci Behav Physiol. 2007 Sep;37(7):721-4. doi: 10.1007/s11055-007-0073-9.
2
Involvement of the rat caudate nucleus in the immunostimulatory effect of DAGO.
Neurosci Behav Physiol. 2001 May-Jun;31(3):323-6. doi: 10.1023/a:1010394820455.

本文引用的文献

1
An inhibitor of opioid peptide degradation produces analgesia in mice.一种阿片肽降解抑制剂在小鼠中产生镇痛作用。
Pharmacol Biochem Behav. 1980 Nov;13(5):715-8. doi: 10.1016/0091-3057(80)90016-7.
2
The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice.脑啡肽酶抑制剂硫喷妥在小鼠中表现出抗伤害感受活性。
Nature. 1980 Nov 20;288(5788):286-8. doi: 10.1038/288286a0.
3
Radioimmunoassay of methionine(5)-enkephalin sulphoxide: phylogenetic and anatomical distribution.蛋氨酸(5)-脑啡肽亚砜的放射免疫分析:系统发育和解剖学分布
Peptides. 1980 Fall;1(3):211-6. doi: 10.1016/0196-9781(80)90056-x.
4
Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.氟哌啶醇长期治疗后释放调节多巴胺自身受体敏感性的变化。
J Pharmacol Exp Ther. 1983 Aug;226(2):558-64.
5
Regulation of methionine-enkephalin precursor messenger RNA in rat striatum by haloperidol and lithium.氟哌啶醇和锂对大鼠纹状体中甲硫氨酸脑啡肽前体信使核糖核酸的调节作用
Biochem Biophys Res Commun. 1983 Jun 15;113(2):391-9. doi: 10.1016/0006-291x(83)91739-4.
6
The effect of opioid drugs on the release of dopamine and 5-hydroxytryptamine from rat striatum following activation of nicotinic-cholinergic receptors.阿片类药物对烟碱型胆碱能受体激活后大鼠纹状体中多巴胺和5-羟色胺释放的影响。
Eur J Pharmacol. 1983 Aug 19;92(1-2):35-42. doi: 10.1016/0014-2999(83)90105-x.
7
Enkephalin content in rat striatum during prolonged treatment with fluphenazine.氟奋乃静长期治疗期间大鼠纹状体内脑啡肽含量
Neuropeptides. 1984 Nov;4(6):497-505. doi: 10.1016/0143-4179(84)90093-3.
8
Autoradiographic distribution of mu and delta opiate receptors in rat brain using highly selective ligands.使用高选择性配体对大鼠脑中μ和δ阿片受体进行放射自显影分布研究。
Life Sci. 1983;33 Suppl 1:227-30. doi: 10.1016/0024-3205(83)90484-8.
9
Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography.通过光学显微镜放射自显影术区分δ和μ阿片受体定位
Proc Natl Acad Sci U S A. 1980 Oct;77(10):6239-43. doi: 10.1073/pnas.77.10.6239.
10
Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats.
Eur J Pharmacol. 1984 Mar 16;99(1):127-8. doi: 10.1016/0014-2999(84)90445-x.